AAAAAA

   
Results: 1-25 | 26-26
Results: 1-25/26
Defective human T-cell leukaemia virus type 1 (HTLV-1) genomes: No evidence in serologically indeterminate German blood donors but new type detected in established cell lines
Authors: Morozov, VA Ellerbrok, H Fleischer, C Brackmann, HH Pauli, G
Citation: Va. Morozov et al., Defective human T-cell leukaemia virus type 1 (HTLV-1) genomes: No evidence in serologically indeterminate German blood donors but new type detected in established cell lines, J MED VIROL, 66(1), 2002, pp. 102-106
Pain status of patients with severe haemophilic arthropathy
Authors: Wallny, T Hess, L Seuser, A Zander, D Brackmann, HH Kraft, CN
Citation: T. Wallny et al., Pain status of patients with severe haemophilic arthropathy, HAEMOPHILIA, 7(5), 2001, pp. 453-458
Immune tolerance in hemophilia and treatment of hemophiliacs with an inhibitor
Authors: Mariani, G Brackmann, HH
Citation: G. Mariani et Hh. Brackmann, Immune tolerance in hemophilia and treatment of hemophiliacs with an inhibitor, HAEMATOLOG, 86(3), 2001, pp. 225-226
Hemophilia
Authors: Mariani, G Kroner, BL Brackmann, HH
Citation: G. Mariani et al., Hemophilia, N ENG J MED, 345(14), 2001, pp. 1066-1066
Transient loss of T-cell reactivity in a patient with hepatitis C virus reinfection
Authors: Duesberg, U Geulen, O Schneiders, AM Kaiser, R Brackmann, HH Matz, B Sauerbruch, T Spengler, U
Citation: U. Duesberg et al., Transient loss of T-cell reactivity in a patient with hepatitis C virus reinfection, DIGESTION, 64(1), 2001, pp. 66-70
Efficacy of a sucrose-formulated recombinant factor VIII used for 22 surgical procedures in patients with severe haemophilia A
Authors: Scharrer, I Brackmann, HH Sultan, Y Abshire, T Gazengel, C Ragni, M Gorina, E Vosburgh, E Kellermann, E
Citation: I. Scharrer et al., Efficacy of a sucrose-formulated recombinant factor VIII used for 22 surgical procedures in patients with severe haemophilia A, HAEMOPHILIA, 6(6), 2000, pp. 614-618
Intra-articular hyaluronic acid in the treatment of haemophilic arthropathy of the knee. Clinical, radiological and sonographical assessment
Authors: Wallny, T Brackmann, HH Semper, H Schumpe, G Effenberger, W Hess, L Seuser, A
Citation: T. Wallny et al., Intra-articular hyaluronic acid in the treatment of haemophilic arthropathy of the knee. Clinical, radiological and sonographical assessment, HAEMOPHILIA, 6(5), 2000, pp. 566-570
NovoSeven (R) in immune tolerance therapy
Authors: Brackmann, HH Effenberger, E Hess, L Schwaab, R Oldenburg, J
Citation: Hh. Brackmann et al., NovoSeven (R) in immune tolerance therapy, BL COAG FIB, 11, 2000, pp. S39-S44
Congenital deficiency of vitamin K dependent coagulation factors in two families presents as a genetic defect of the vitamin K-epoxide-reductase-complex
Authors: Oldenburg, J von Brederlow, B Fregin, A Rost, S Wolz, W Eberl, W Eber, S Lenz, E Schwabb, R Brackmann, HH Effenberger, W Harbrecht, U Schurgers, LJ Vermeer, C Muller, CR
Citation: J. Oldenburg et al., Congenital deficiency of vitamin K dependent coagulation factors in two families presents as a genetic defect of the vitamin K-epoxide-reductase-complex, THROMB HAEM, 84(6), 2000, pp. 937-941
Human herpesvirus 8 infection in haemophiliacs
Authors: Eis-Hubinger, AM Matz, B Effenberger, W Brackmann, HH Neipel, F
Citation: Am. Eis-hubinger et al., Human herpesvirus 8 infection in haemophiliacs, THROMB HAEM, 84(3), 2000, pp. 515-517
Sucrose formulated recombinant human antihemophilic factor VIII is safe and efficacious for treatment of hemophilia A in home therapy - Results of a multicenter, international, clinical investigation
Authors: Abshire, TC Brackmann, HH Scharrer, I Hoots, K Gazengel, C Powell, JS Gorina, E Kellermann, E Vosburgh, E
Citation: Tc. Abshire et al., Sucrose formulated recombinant human antihemophilic factor VIII is safe and efficacious for treatment of hemophilia A in home therapy - Results of a multicenter, international, clinical investigation, THROMB HAEM, 83(6), 2000, pp. 811-816
Antibodies to factor VIII in hemophilia A patients
Authors: Brackmann, HH Schwaab, R Effenberger, W Hess, L Hanfland, P Oldenburg, J
Citation: Hh. Brackmann et al., Antibodies to factor VIII in hemophilia A patients, VOX SANGUIN, 78, 2000, pp. 187-190
A novel cause of mild/moderate hemophilia A: mutations scattered in the factor VIIIC1 domain reduce factor VIII binding to von Willebrand factor
Authors: Jacquemin, M Lavend'homme, R Benhida, A Vanzieleghem, B d'Oiron, R Lavergne, JM Brackmann, HH Schwaab, R VandenDriessche, T Chuah, MKL Hoylaerts, M Gilles, JGG Peerlinck, K Vermylen, J Saint-Remy, JMR
Citation: M. Jacquemin et al., A novel cause of mild/moderate hemophilia A: mutations scattered in the factor VIIIC1 domain reduce factor VIII binding to von Willebrand factor, BLOOD, 96(3), 2000, pp. 958-965
Induction of immune tolerance with recombinant factor VIII in haemophilia A patients with inhibitors
Authors: Batlle, J Lopez, MF Brackmann, HH Gaillard, S Goudemand, J Humbert, J De Moerloose, P Maass, E Mauz-Korholz, C Sultan, Y Stieltjes, N
Citation: J. Batlle et al., Induction of immune tolerance with recombinant factor VIII in haemophilia A patients with inhibitors, HAEMOPHILIA, 5(6), 1999, pp. 431-435
Highly sensitive and species-specific assay for quantification of human transgene expression levels
Authors: Haack, A Poller, W Schneider-Rasp, S Thalheimer, P Schmitt, C Hanfland, P Brackmann, HH Schwaab, R
Citation: A. Haack et al., Highly sensitive and species-specific assay for quantification of human transgene expression levels, HAEMOPHILIA, 5(5), 1999, pp. 334-339
German recommendations for immune tolerance therapy in type A haemophiliacs with antibodies
Authors: Brackmann, HH Lenk, H Scharrer, I Auerswald, G Kreuz, W
Citation: Hh. Brackmann et al., German recommendations for immune tolerance therapy in type A haemophiliacs with antibodies, HAEMOPHILIA, 5(3), 1999, pp. 203-206
Hamstring release and posterior capsulotomy for fixed knee flexion contracture in haemophiliacs
Authors: Wallny, T Eickhoff, HH Raderschadt, G Brackmann, HH
Citation: T. Wallny et al., Hamstring release and posterior capsulotomy for fixed knee flexion contracture in haemophiliacs, HAEMOPHILIA, 5, 1999, pp. 25-27
'Autoreplication' of the vector genome in recombinant adenoviral vectors with different E1 region deletions and transgenes
Authors: Marienfeld, U Haack, A Thalheimer, P Schneider-Rasp, S Brackmann, HH Poller, W
Citation: U. Marienfeld et al., 'Autoreplication' of the vector genome in recombinant adenoviral vectors with different E1 region deletions and transgenes, GENE THER, 6(6), 1999, pp. 1101-1113
Analysis of expression kinetics and activity of a new B-domain truncated and full-length FVIII protein in three different cell lines
Authors: Haack, A Schmitt, C Poller, W Oldenburg, J Hanfland, P Brackmann, HH Schwaab, R
Citation: A. Haack et al., Analysis of expression kinetics and activity of a new B-domain truncated and full-length FVIII protein in three different cell lines, ANN HEMATOL, 78(3), 1999, pp. 111-116
Parvovirus B19 DNA contamination in coagulation factor VIII products
Authors: Eis-Hubinger, AM Sasowski, U Brackmann, HH
Citation: Am. Eis-hubinger et al., Parvovirus B19 DNA contamination in coagulation factor VIII products, THROMB HAEM, 81(3), 1999, pp. 476-477
Inhibitors in German hemophilia A patients treated with a double virus inactivated factor VIII concentrate bind to the C2 domain of FVIII light chain
Authors: Laub, R Di Giambattista, M Fondu, P Brackmann, HH Lenk, H Saenko, EL Felch, M Scandella, D
Citation: R. Laub et al., Inhibitors in German hemophilia A patients treated with a double virus inactivated factor VIII concentrate bind to the C2 domain of FVIII light chain, THROMB HAEM, 81(1), 1999, pp. 39-44
Prevalence and outcome of intracranial haemorrhage in haemophiliacs - a survey of the paediatric group of the German Society of Thrombosis and Haemostasis (GTH)
Authors: Klinge, J Auberger, K Auerswald, G Brackmann, HH Mauz-Korholz, C Kreuz, W
Citation: J. Klinge et al., Prevalence and outcome of intracranial haemorrhage in haemophiliacs - a survey of the paediatric group of the German Society of Thrombosis and Haemostasis (GTH), EUR J PED, 158, 1999, pp. S162-S165
Protection against parenteral HIV-1 infection by homozygous deletion in the C-C chemokine receptor 5 gene
Authors: Kupfer, B Kaiser, R Brackmann, HH Effenberger, W Rockstroh, JK Matz, B Schneweis, KE
Citation: B. Kupfer et al., Protection against parenteral HIV-1 infection by homozygous deletion in the C-C chemokine receptor 5 gene, AIDS, 13(9), 1999, pp. 1025-1028
Antigen-specific cytokine response to hepatitis C virus core epitopes in HIV/hepatitis C virus-coinfected patients
Authors: Woitas, RP Rockstroh, JK Beier, I Jung, G Kochan, B Matz, B Brackmann, HH Sauerbruch, T Spengler, U
Citation: Rp. Woitas et al., Antigen-specific cytokine response to hepatitis C virus core epitopes in HIV/hepatitis C virus-coinfected patients, AIDS, 13(11), 1999, pp. 1313-1322
Induction of immune tolerance in haemophilia A inhibitor patients by the 'Bonn protocol': Predictive parameter for therapy duration and outcome
Authors: Oldenburg, J Schwaab, R Brackmann, HH
Citation: J. Oldenburg et al., Induction of immune tolerance in haemophilia A inhibitor patients by the 'Bonn protocol': Predictive parameter for therapy duration and outcome, VOX SANGUIN, 77, 1999, pp. 49-54
Risultati: 1-25 | 26-26